AGEs	advanced glycation end products
BSA	bovine serum albumin
BSA124–130	BSA peptide including residues 124–130 with Lys127 glycated into CEL
CAPRI	critical assessment of predicted interactions
CEL	carboxyethyl lysine
CML	carboxymethyl lysine
CSA	chicken serum albumin
DM	diabetes mellitus
ESA	equine serum albumin
FA	fatty acid
FA1–7	fatty acid binding sites 1–7 in serum albumin
gBSA	glycated bovine serum albumin
gHSA	glycated human serum albumin
gHSA–V	complex of gHSA with the V-domain of RAGE
gSA	glycated serum albumin
GLUC	β-D-glucopyranose
HMGB1	high-mobility group protein B1
HSA	human serum albumin
IS1–3	interaction surface 1–3 (experimentally obtained areas on the surface of RAGE interacting with AGE-peptides and gBSA)
IUPAC	international union of pure and applied chemistry
LINCS	linear constraint solver for molecular simulations
LSA	leporine serum albumin
MD	molecular dynamics
NMR	nuclear magnetic resonance
NPT	constant number of particles N, pressure P and temperature T
NVT	constant number of particles N, volume V and temperature T
OLA	oleic acid
PDB	Protein Data Bank
RAGE	receptor for advanced glycation end products
Rg	radius of gyration;
RMSD	root mean square deviation
RMSF	root mean square fluctuation
SASA	solvent accessible surface area
SF	scoring function
TIP3P	transferable intermolecular potential with 3 points
VMD	visual molecular dynamics